Posts Tagged ‘biopharma’
Trend: Biopharma embraces digital cognitive assessments to identify behavioral health biomarkers
_______ The hunt for behavioral health biomarkers is harnessing digital health at the research stage (MedCity News): “Digital health companies are going through an interesting transformation as research institutions realize the benefit of their technology to collect and manage data for a host of studies. The biopharma industry’s embrace of some digital health tools to manage…
Read MoreAkili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table
—– Akili Adds Amgen Ventures and M Ventures* to Series B Financing, Increasing Round to $42.4 Million (press release): “Akili Interactive Labs, Inc. (“Akili”), a digital medicine company developing novel, non-pharmacological therapeutics and diagnostics for cognitive disorders, today announced an $11.9 million expansion of its recent Series B financing.
Read More